1st approved Symbicort generic, Breyna, now available in US
2023年8月7日 · The inhaled medication — the first Symbicort generic to be approved by the U.S. Food and Drug Administration — will become immediately available to eligible patients.. Like Symbicort, Breyna is approved as a maintenance therapy to lower airflow obstruction and prevent exacerbations in people with COPD, and for asthma patients, ages 6 and older.
Low-dose Morphine Improves Health in COPD Patients With …
2020年9月3日 · So, researchers based at the Maastricht University in the Netherlands designed the Morphine for Treatment of Dyspnea in Patients With COPD (MORDYC) Phase 4 study (NCT02429050).It investigated whether regular, low-dose, oral sustained-release morphine improved health in COPD patients with moderate-to-very-severe chronic breathlessness.
LupinHaler, generic version of Spiriva HandiHaler, available in US
2023年8月28日 · In Europe, generics of Boehringer Ingelheim’s Spiriva HandiHaler began launching in 2021, including ones from Glenmark Pharmaceuticals and Phargentis, but these medications haven’t become available in the U.S.. COPD is a chronic lung disease wherein the airways become blocked, leading to progressively worsening disease symptoms that include …
Trelegy Ellipta Reduces COPD Exacerbations and Improves Lung …
2018年4月24日 · The Phase 3 IMPACT study compared Trelegy to other common COPD medications in 10,355 patients in 37 countries, according to GlaxoSmithKline (GSK) and Innoviva.. Findings from the study, titled “Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD,” were recently published in the New England Journal of Medicine. …
COPD Trial Shows Breztri Aerosphere Significantly Reduces...
2020年6月30日 · The findings were presented by the company at the American Thoracic Society virtual Scientific Symposium and published in The New England Journal of Medicine, in an article titled “ Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.”. Breztri Aerosphere, known as PT010 outside of China, is a triple combination therapy made up …
FDA Approval Sought for New Generic Version of Advair Diskus
2021年4月8日 · Such an approval would be expected to provide a less-expensive alternative to the inhalation treatment that generated about $3 billion in total U.S. sales for the 12 months ending in February 2021, according to Lannett.
Zephyr Valve Boosts Lung Function, Life Quality for COPD Patients:...
2021年5月27日 · Previous data from the trial indicated that, six months after treatment, participants given BLVR had significantly better lung function and quality of life than those treated with best standard care alone.. Newly presented data came from participants for whom longer-term data was available, including 48 patients with complete data up to 12 months, 40 with …
AstraZeneca caps out-of-pocket costs of meds for eligible patients
2024年3月25日 · Viatris, which markets Breyna, also has a copay assistance program for commercially insured patients through which a monthly supply could cost as little as $20 in out-of-pocket costs.A patient assistance program also is available to help those with financial needs access Viatris’ medications at no charge.. AstraZeneca noted it will continue to offer discounts …
FDA Approves Zephyr Valve for Patients with Severe Emphysema
2018年7月10日 · The use of Zephyr valves has been linked with improved breathing and improved quality of life for patients. Prior to approving Zephyr valves, the FDA reviewed clinical data from a multi-center study assessing 190 patients with severe emphysema (NCT01796392).. In total, 128 of 190 patients were treated with Zephyr valves in addition to optimal medical …
First Generic of COPD Inhaler Advair Diskus Approved By FDA
2019年2月8日 · In 2013, the FDA published product-specific guidance for those attempting to develop a generic product for Advair Diskus, developed by GlaxoSmithKline. “We are committed to advancing new guidance for sponsors to make the development of generic versions of complex products more efficient, and we’re prioritizing review of many applications covering proposed …